Related Experiment Videos
Does tuberin function as a tumor suppressor in the cerebral lesions of tuberous sclerosis? Early observations
Brain Pathology (Zurich, Switzerland)
|October 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Design and modeling of Cf-252 -based neutron irradiator for NAA: MCNP6 simulations of dose rate and neutron fluxes.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2025
A compact, asymmetric probe, planar transient grating spectroscopy system.
The Review of scientific instruments·2025
Accelerating plasma and radiation surface science using transient grating spectroscopy.
The Review of scientific instruments·2025
A facility for cryogenic ion irradiation and in situ characterization of rare-earth barium copper oxide superconducting tapes.
The Review of scientific instruments·2024
Issues in implementing prenatal screening for cystic fibrosis: results of a working conference.
Genetics in medicine : official journal of the American College of Medical Genetics·2001
Artificial intelligence-based statistical modeling delineates architectural distortion in focal cortical dysplasia.
Brain pathology (Zurich, Switzerland)·2026
Neuropathology of a patient with Parkinson's disease and biallelic expansion in RFC1.
Brain pathology (Zurich, Switzerland)·2026
Circumscribed Meningeal Melanocytic Neoplasms: CNS WHO Grade, Molecular Profile, and Clinical Outcomes.
Brain pathology (Zurich, Switzerland)·2026
PTEN homozygous deletion is a negative prognostic factor in tumor treating fields-treated glioblastoma, IDH wildtype patients.
Brain pathology (Zurich, Switzerland)·2026
Molecular profiling of pediatric medulloblastoma in Kazakhstan: Genomic alterations, subgroup distribution, and survival.
Brain pathology (Zurich, Switzerland)·2026
Clinical evaluation of the CrossNN DNA methylation classifier for central nervous system tumors.
Brain pathology (Zurich, Switzerland)·2026
ANAPC7 promotes triple-negative breast cancer progression through ANAPC2-dependent degradation of PCGF2 and activation of STAT3.
Molecular cancer research : MCR·2026
pH-Responsive drug delivery system for tumor therapy.
Nanoscale·2026
Spatiotemporally controlled degradation of CDK6 via light-triggered ROS generation: uncovering the proximity effect-mediated dual target depletion.
Organic & biomolecular chemistry·2026
Targeting RAS for Pancreatic Cancer Interception.
Cancer discovery·2026